|
|
||||||||
Departments of 1 Veterinary Pharmacology and 2 Anatomy, Faculty of Agriculture, Miyazaki University, Miyazaki 889-2192, Japan
| |
ABSTRACT |
|---|
|
|
|---|
We
examined how monocrotaline (MCT), which impairs the endothelium and
causes pulmonary hypertension, altered the endothelial regulation of
pulmonary artery functions. Rats were given a single injection of MCT
(60 mg/kg sc). Pulmonary arteries were depolarized to
48.3 ± 2.6 and
39.8 ± 2.2 mV at 2 and 3 wk after treatment with MCT,
respectively (control arteries
59.9 ± 1.9 mV). The basal tone
in the resting state was only slightly elevated at 3 wk in
endothelium-intact arteries. Removal of the endothelium caused further
depolarization in MCT-affected arteries at 2 wk, but not at 3 wk, and
greatly elevated the basal tone at 2 and 3 wk.
N
-nitro-L-arginine (200 µM), a
nitric oxide synthase inhibitor, also caused depolarization in
endothelium-intact arteries in both groups and elevated the basal tone
of MCT-affected arteries. The relaxant responses of pulmonary arteries
to ACh and A-23187 were depressed at 2 and 3 wk after MCT treatment.
Thus chronic impairment of the endothelium altered the property of the
pulmonary artery leading to depolarization. During the early stage of
depolarization, a rise in the basal tone was offset by nitric oxide
released from the injured endothelium.
nitric oxide; membrane potential; depolarization; sodium nitroprusside; resting tone
| |
INTRODUCTION |
|---|
|
|
|---|
MONOCROTALINE (MCT) is an inactive alkaloid obtained from seeds of Crotalaria sp. and is biotransformed to toxic metabolites such as MCT pyrrole in the liver (12). When MCT is administered systemically (5, 9, 17), the arterial bed that is first encountered by the metabolite is the pulmonary circulation, so it preferentially injures the pulmonary artery endothelium (12, 36). As a result of the impairment, an animal given MCT exhibits pulmonary hypertension characterized by an increase in pulmonary artery resistance and right ventricular hypertrophy (5, 9, 17, 30). For this characteristic, this alkaloid has been used as a model to explore the process of pulmonary hypertension or the resultant cardiac hypertrophy and to find an appropriate intervention for treatment of pulmonary hypertension-related diseases. To clarify why the vascular resistance increases during MCT-induced pulmonary hypertension, several attempts have been made by observing responses of MCT-affected pulmonary arteries to vasorelaxing or vasoconstricting agents. However, the data from such studies were conflicting, i.e., responses to vasoconstricting agents, which varied from enhancement (10, 11) to depression (2, 15, 32), compared with the control responses. This inconsistency means that alterations of responsiveness to vasoactive substances do not have a causal relationship to an increase in the pulmonary artery resistance.
The resting membrane potential is an important determinant of vascular tone. The endothelium exerts a hyperpolarizing effect on the underlying vascular smooth muscle through the action of nitric oxide (NO) (29), prostacyclin (20), or endothelium-derived hyperpolarizing factor (EDHF) liberated from the endothelium (21) or through direct coupling between endothelial cells and smooth muscle cells (35). In 1982, Suzuki and Twarog (27) showed that the main pulmonary artery was depolarized, while the small pulmonary artery was hyperpolarized, during MCT- or hypoxia-induced pulmonary hypertension in rats. However, at the time of their work, the importance of endothelial control on the membrane property of smooth muscle cells had not been recognized, and it is uncertain whether the endothelium was preserved in their preparations. Since that time, the relationship between the endothelium and electrical properties of vascular smooth muscle in this model has not been thoroughly investigated. Therefore, it is still unclear whether an increase in vascular resistance is associated with a change in the membrane potential in this model. In this study we observed morphological and functional changes in the pulmonary artery in rats treated with MCT and examined how the hyperpolarizing and relaxing effects of the endothelium and the membrane property of vascular smooth muscle cells were altered during the MCT-induced pulmonary hypertension.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Preparations. Six-week-old male Wistar rats received a single injection of MCT (60 mg/kg sc; Sigma Chemical, St. Louis, MO), which had been dissolved in 1 N HCl, diluted into saline, and neutralized to pH 7.4 with NaOH, or the same volume of saline (control). The rats were fed and given water ad libitum. At 7, 14, or 21 days after the injection, the rats were killed under light ether anesthesia. The lung, the right ventricle, and the left ventricle attached to the septum were isolated from rats used for the tension experiments, and their weights were measured. The main pulmonary artery was dissected, and connective tissues were cleaned off. The artery segment was cut open, and a 5-mm-long, 2-mm-wide strip was made. When needed, the endothelium was gently removed with a cotton swab.
Morphological study. For light-microscopic examination of the artery, isolated main pulmonary artery rings were fixed in 10% Formalin and embedded in paraffin (immersion fixation). The sections were sliced at 4 µm and stained with hematoxylin-eosin or resorcin-fuchsin. The latter staining was used to specify the locus of the innermost lamina in the medial layer. In a separate experiment to observe the endothelium in a condition closer to that in vivo, rats were anesthetized with pentobarbital sodium (50 mg/kg), and the caudal vena cava was cannulated with a polyethylene tube. Physiological saline solution (PSS) was infused from the cannula and drained from an incision in the abdominal aorta, and 10% Formalin was slowly infused (perfusion fixation). A segment of the main pulmonary artery was then isolated and processed for light microscopy as described above. A microscopic image of the cross section of artery was acquired by a computer. To measure the distance between the endothelial cell and the medial layer, the inner circumference of the artery ring was marked at three points with an equal distance. The distance was measured at each point by use of Canvas 6.0 software and averaged.
To measure the cross-sectional area of the artery, the muscle strips that had been used for tension experiments were sandwiched in an incision made in a rat liver block, fixed with 10% Formalin, and processed for light microscopy. This procedure prohibited a collapse of thin strips during tissue preparation and allowed precise measurement for normalization of the muscle tension to a cross-sectional area of artery. A cross-sectional area of the medial layer was measured using Canvas 6.0 after the image had been acquired by a computer.Tension measurement.
The strip was suspended in an organ bath containing 10 ml of PSS of the
following composition (mM): 136.8 NaCl, 5.4 KCl, 2.5 CaCl2,
1.0 MgCl2, 11.9 NaHCO3, and 5.5 glucose (pH
7.3-7.4 when gassed with 95% O2-5% CO2)
at 37°C. A change in tension was recorded isometrically under resting
tension of 400 mg. To measure the active tone developed spontaneously
under the resting condition (basal tone), preparations were stabilized
by three challenges with high-KCl solution, and the external medium was
then switched from PSS to Ca2+-free PSS containing 1 mM
EGTA. A drop of the tension from the resting level was measured. A
high-KCl (65.4 mM) solution was made by replacement of 60 mM NaCl for
isosmolar KCl. When the endothelium-dependent relaxation was measured,
the artery was precontracted by 10 µM PGF2
, and ACh or
A-23187 was then cumulatively added.
Membrane potential measurement.
The strip was mounted horizontally in a superfusion bath with the
adventitial layer facing up. The preparation was superfused with PSS at
a rate of 4 ml/min. A glass microelectrode with a tip resistance of
60-80 M
when filled with 3 M KCl was penetrated into a cell
from the adventitial side. The signal was fed into a microelectrode
amplifier (model MEZ-8301, Nihon-Kohden, Tokyo, Japan) and recorded on
a pen-writing oscillograph (San'ei Recti-Hori, Tokyo, Japan) or stored
on a VCR tape by use of a modified PCM processor (model PCM-501 ES,
Sony, Tokyo, Japan).
Cytosolic Ca2+ concentration
measurement.
For measurement of the cytosolic Ca2+ concentration
([Ca2+]i) of the pulmonary artery, the strip
was loaded overnight with 5 µM fura PE3-AM (TEFLAB, Austin, TX) that
had been sonicated together with 0.02% cremophore EL in PSS. Overnight
loading did not affect the contractile response to 65.4 mM KCl or
PGF2
. The strip was then placed in a bath constructed in
a fluorometer (model CAF-100, JASCO, Tokyo, Japan). Fluorescence at 500 nm after excitation at 340 and 380 nm was monitored. At the end of the
experiment, 10 µM ionomycin and then 10 mM EGTA were applied to
obtain fluorescence at maximum and minimum
[Ca2+]i, respectively. The signals of the
tension and [Ca2+]i were stored on the hard
disk of an IBM-compatible personal computer, and the data were analyzed
with Microsoft Excel. Background fluorescence was subtracted from all
the data. [Ca2+]i was calculated as described
by Grynkiewicz et al. (8) with use of a dissociation
constant for fura PE3 of 290 nM (31).
| |
RESULTS |
|---|
|
|
|---|
Development of pulmonary hypertension.
After injection of MCT (60 mg/kg sc), the increase in body weight was
less at 3 wk than in the control group (data not shown). The
lung-to-body weight ratio increased at 2 and 3 wk after the injection
of MCT, whereas that in the control group decreased at later times. The
right ventricle-to-left ventricle + septum weight ratio was larger
at 2 and 3 wk in the MCT group than in the control group (Table
1). Because these changes have been considered an index of pulmonary hypertension (5, 17), it is suggested that the pulmonary hypertension and the consequent right
ventricular hypertrophy were established between 2 and 3 wk after MCT
treatment in this study. At 4 wk after the injection, about one-half of
the animals treated with MCT died. Therefore, we did not use the
pulmonary artery after 4 wk.
|
|
|
Development of the basal tone and decrease in the resting membrane
potential.
After each strip was equilibrated with PSS in an organ bath under basal
tension of 400 mg, the external medium was switched to
Ca2+-free PSS containing 1 mM EGTA. In a preparation where
the endothelium was preserved, Ca2+-free EGTA solution did
not lower the tension in control arteries and in those treated with MCT
for 1 or 2 wk. However, it slightly lowered the tension in the arteries
at 3 wk after treatment with MCT, suggesting that the MCT-affected
arteries at this stage had an active basal tone in the resting state
(Fig. 2, A and B).
When the endothelium was removed, the basal tone was increased in the control and MCT-affected arteries. The basal tone of
endothelium-denuded arteries after 2 or 3 wk of treatment with MCT was
much greater than that in the time-matched controls (Fig.
2B). In a preliminary experiment, we stretched the
endothelium-intact artery to 1.3 times the original length instead of
subjecting it to 0.4 g of pretension and measured the basal
tension by changing the external medium to Ca2+-free EGTA
solution. In this case, too, the basal tension was higher in arteries
at 3 wk after treatment with MCT than in control arteries (data not
shown). Therefore, it is obvious that the tension in the resting state
increased in MCT-affected arteries irrespective of the experimental
condition to give pretension.
|
58.4 ± 1.5 mV, n = 16) was
not significantly different from that of the control group (
59.9 ± 1.9 mV, n = 14). At 2 or 3 wk after MCT, the resting
membrane potential decreased progressively, whereas that in the control group remained constant (Fig. 2C). Spontaneous spike
activity was observed in arteries at 2 wk and, more frequently, 3 wk
after treatment with MCT (see Fig. 5). When the endothelium was removed from the control arteries, the resting membrane potential was depolarized by 5.6 ± 0.6 mV (n = 14). Removal of
the endothelium also depolarized the arteries at 2 wk after treatment
with MCT and increased the amplitude of spike, indicating that the
spike activity depended on the membrane potential. The magnitude of depolarization on removal of endothelium in that group (6.5 ± 1.3 mV, n = 9) was similar to that in the control group.
However, the deendothelialization did not significantly enhance
depolarization of the arteries at 3 wk after treatment with MCT (Fig.
2C).
As well as the endothelial denudation, addition of
N
-nitro-L-arginine
(L-NNA, 200 µM), an NO synthase inhibitor, significantly depolarized the membrane potential in control and MCT-affected arteries
in which the endothelium was preserved (Fig.
3A). The magnitude of
depolarization due to L-NNA in control and MCT-affected arteries at 3 wk after treatment was similar (6.3 ± 2.0 and
6.1 ± 1.9 mV, n = 6, respectively), despite
different resting membrane potentials. L-NNA increased
the basal tone in MCT-affected arteries but not in control arteries
(Fig. 3B).
|
Response to NO-dependent vasodilators.
Figure 4 shows the dose-dependent
relaxant response to ACh and A-23187 in control and MCT-affected
arteries precontracted with 10 µM PGF2
. The developed
tension per cross-sectional area of the medial layer in response to 10 µM PGF2
in the MCT group at each week was not
different from that in the time-matched control. The relaxation to ACh
in arteries at 1 wk after treatment with MCT was not different from the
control condition but was significantly depressed at 2 and 3 wk. The
depression of the response was maximum at 2 wk after treatment. The
relaxant response to A-23187 at the lowest concentration was depressed
at 1 wk after treatment with MCT, and the overall responses were
depressed at 2 or 3 wk. ACh- and A-23187-induced relaxations were
abolished by endothelial denudation or pretreatment with 200 µM
L-NNA.
|
|
|
Changes in [Ca2+]i
during washout with Ca2+-free medium.
As shown in Fig. 2A, when a contractile stimulation (high
KCl) was removed, relaxation of MCT-affected arteries was slow compared with that of control arteries. This was also observed in the case of
PGF2
-induced contraction (data not shown). To observe whether the depression of relaxation accompanied a slow decline of
[Ca2+]i, we measured
[Ca2+]i in fura PE3-AM-loaded strips.
The deendothelialized artery was contracted by 65.4 mM KCl, and 5 min
later it was rinsed with Ca2+-free 1 mM EGTA solution. At
the maximum contraction due to KCl, [Ca2+]i
and tension, expressed as an absolute value, were significantly higher
in arteries at 3 wk after treatment with MCT than in control arteries,
although the tension per cross-sectional area was not different between
the two groups (387 ± 46 and 407 ± 75 mg/mm2 in
control and MCT groups, respectively). During rinsing with Ca2+-free EGTA solution, [Ca2+]i
and tension were always higher in the MCT-treated group than in the
control group (Fig. 7, A and
C). To compare the rate of decline of
[Ca2+]i and tension, the data were normalized
to the respective peak value in each preparation. For kinetics
analysis, [Ca2+]i and tension are expressed
on a logarithmic scale (Fig. 7, B and D).
Obviously, the rate of decline in [Ca2+]i or
tension was slowed in MCT-affected arteries. The
[Ca2+]i curve is a sum of two exponential
decays. The rate constant for the early phase was 0.96 and 0.88 min
1 in control and MCT groups (half-time = 0.72 and
0.79 min), respectively, whereas that for the late phase was 0.16 and
0.13 min
1 (half-time = 4.3 and 5.2 min),
respectively.
|
| |
DISCUSSION |
|---|
|
|
|---|
From the results in the present study, temporal changes in structures and functions of the pulmonary endothelium and vascular smooth muscle after treatment with MCT are summarized as follows: 1) Thickening of the medial layer and depression of the relaxant response to ACh or A-23187 were evident at 2 wk after MCT treatment and exhibited no further development at 3 wk. 2) Detachment of endothelial cells and depolarization were more severe at 3 wk than at 2 wk. Also, the lung-to-body weight ratio and the right ventricle-to-left ventricle + septum weight ratio were also higher at 3 wk than at 2 wk. 3) Elevation of basal tone in the resting state of endothelium-intact pulmonary arteries was observed only at 3 wk after treatment with MCT, whereas that of deendothelialized arteries was evident at 2 wk and, more intensely, at 3 wk. Temporal dissociation among the above parameters suggests that a primary toxic effect of MCT on the endothelium, which was typically shown as depression of the endothelium-dependent relaxant response, was maximal at 2 wk, whereas some of changes secondary to endothelial impairment (depolarization, an increase in the basal tone, and ventricular hypertrophy) were progressive and aggravate the pathological condition, which became lethal beyond 3 wk.
The pulmonary endothelium exerted a hyperpolarizing effect on smooth muscle cells in the resting state in control and MCT-affected arteries, since removal of the endothelium or addition of L-NNA caused depolarization of the smooth muscle. ACh-induced hyperpolarization was endothelium dependent and was blocked by pretreatment with L-NNA. The NO donor SNP hyperpolarized the membrane, consistent with the reports that NO hyperpolarized the rat pulmonary artery (3, 37). Taken together, these facts indicate that NO mediates the endothelium-dependent hyperpolarization in rat pulmonary arteries in the resting state or after stimulation with ACh. An EDHF, which is not a product of NO synthase or cyclooxygenase (21), is unlikely to exert a significant hyperpolarizing effect in the preparation tested here.
The hyperpolarization response to SNP was larger when the resting membrane potential was more depolarized. This is reasonable, because NO-induced hyperpolarization is due to activation of K+ channels (19, 24, 37), and the hyperpolarization as a result of K+ channel activation is larger when the membrane potential is more positive to the equilibrium potential for K+. In contrast to the response to SNP, the hyperpolarization to ACh was similar in MCT-affected and control arteries. Likewise, the depolarization caused by removal of endothelium or addition of L-NNA was also similar in the two groups. If the amount of NO available to smooth muscle cells is the same, the resultant hyperpolarization should be larger in more depolarized arteries (i.e., MCT-affected arteries). Compared with the response to SNP, the response to ACh, L-NNA, or deendothelialization was too small in MCT-affected arteries. Consequently, we conclude that the amount of NO that reached smooth muscle cells was less in MCT-affected than in control arteries when the arteries were rested or when they were stimulated with ACh. Depression of the endothelium-dependent relaxant response to ACh or A-23187 after treatment with MCT supports this idea.
However, this does not necessarily mean that NO production in endothelial cells was reduced after treatment with MCT. It has been shown that expression of endothelial NO synthase was increased rather than decreased in cultured endothelial cells treated with MCT (26) and that NO production in the MCT-injured lung was similar to that in the control lung (34). Consistent with these findings, mRNA encoding endothelial NO synthase was increased in MCT-affected pulmonary arteries (22). From these reports, it is conceivable that the MCT-affected endothelium is still capable of producing NO in an amount comparable to that produced by the control endothelium. Although we did not measure production of NO, even if the synthesis of NO was not decreased, it is possible that a quantity of NO molecules released from endothelial cells diffused away from smooth muscle cells of MCT-affected arteries, because endothelial cells exfoliated from the smooth muscle cells. It is also possible that if depolarization occurs in MCT-injured endothelial cells, a decrease in electrochemical Ca2+ gradient would attenuate Ca2+ entry into endothelial cells and thereby reduce production of NO (13).
Removal of the endothelium depolarized control arteries by ~6 mV. In contrast, the resting membrane potential of MCT-affected arteries was 10-20 mV more positive than that of control arteries. Therefore, a decrease in the hyperpolarizing effect of the endothelium is not a sole mechanism for the depolarization of MCT-affected arteries. Obviously, the membrane property of smooth muscle cells was altered toward depolarization after treatment with MCT. Because MCT pyrrole, an active metabolite of MCT (12, 36), did not exert any influence on cultured pulmonary artery cells, whereas it damaged endothelial cells (25), the alteration in the membrane property was probably secondary to long-term impairment of the endothelium but not a result of the direct action of the compound on smooth muscle cells. A problem regarding changes in smooth muscle functions is why a long-term decrease of endothelial control alters the membrane property of smooth muscle cells. It is possible that when the normal endothelium-smooth muscle coupling is disrupted, some factor from leukocytes, platelets, or endothelial cells is released (6, 7) and alters the properties of endothelial and smooth muscle cells. Alternatively, under control of these factors, proliferated smooth muscle cells could show a phenotype different from normal cells. Adhesion of leukocytes to endothelial cells in MCT-affected arteries suggests that endothelium-leukocyte interaction affected smooth muscle cells (14, 23). It remains to be clarified what factor(s) is responsible for the remodeling of the pulmonary artery.
An interesting finding in this study is that, despite considerable
depolarization, the basal tone did not develop (1-2 wk) or only
slightly developed (3 wk) in MCT-affected arteries when the endothelium
was preserved. This suggests that the amount of NO released from
impaired endothelial cells in the resting state was enough to cancel
the influence of depolarization on the resting tension. Only when the
membrane potential is depolarized to around
40 mV or spontaneous
release of NO decreases considerably, the tonus in the resting state
may increase. At 2 wk after treatment with MCT, right ventricular
hypertrophy already appeared, whereas tonus of main pulmonary artery
(endothelium intact) did not develop. This yields the impression that a
change in the artery is not responsible for development of pulmonary
hypertension and ventricular hypertrophy. In our preliminary
experiments, however, the basal tone of the intrapulmonary artery was
already elevated at 2 wk (unpublished data), suggesting that the
impairment is likely to occur earlier in smaller arteries. Narrowing of
the vessel lumen as a result of medial thickening and increase in the
tonus of smaller arteries may contribute to an increase in the
pulmonary artery resistance at an earlier stage, leading to right
ventricular hypertrophy. Beyond 3 wk, however, the basal tone would be
elevated in large arteries; this could worsen the condition.
Na+/Ca2+ exchange is one of determinants of [Ca2+]i. Na+/Ca2+ exchange in smooth muscle is electrogenic in nature (1, 16); therefore, it depends on the membrane potential. After the high-K+ medium was switched to Ca2+-free EGTA solution (5.4 mM K+), [Ca2+]i decreased with kinetics of double-exponential decay. When high K+ is removed, the membrane potential cannot rapidly repolarize to the resting level. Because Ca2+ extrusion through the exchanger occurs at a voltage negative to the equilibration potential for Na+/Ca2+ exchange (18), Ca2+ extrusion through Na+/Ca2+ exchange may be reflected in the late component of [Ca2+]i decay. Therefore, a smaller rate constant of the late component in the MCT group means that the depolarization inhibited the Ca2+ extrusion through the Na+/Ca2+ exchange. This change in Ca2+ handling increases [Ca2+]i at the steady state and contributes to an increase in the basal tone. A deficiency in Ca2+ extrusion through Na+/Ca2+ exchange may be less as long as the endothelium releases NO, since a cGMP-elevating agent stimulates Na+/Ca2+ exchange (4). Consistent with this, an increase in the basal tone was quite small in endothelium-intact arteries in the MCT-affected group. Another contribution of depolarization to an increase in the basal tone is activation of L-type Ca2+ channels. This appears to occur in MCT-induced hypertensive vessels, since Ca2+ channel blockers more effectively inhibited the norepinephrine- or serotonin-induced contractions in MCT-affected than in control arteries (28, 33).
In summary, as a result of damage to the endothelium by MCT, the influence of the endothelium on smooth muscle cells is reduced and the membrane property of smooth muscle cells is altered, leading to depolarization of the pulmonary artery. At the early stage of depolarization, however, tension of the pulmonary artery is kept low by the relaxing action of NO released from the injured endothelium.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Dr. Masahiro Ikeda and Christer Hellberg for pertinently helping us and reading the manuscript.
| |
FOOTNOTES |
|---|
Present address of M. Nakai: Dept. of Veterinary Biosciences, University of Illinois at Urbana-Champaign, 2001 South Lincoln Ave., Urbana, IL 61802.
Address for reprint requests and other correspondence: K. Ito, Dept. of Veterinary Pharmacology, Faculty of Agriculture, Miyazaki University, Miyazaki 889-2192, Japan (E-mail: ito{at}grc.miyazaki-u.ac.jp).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 2 November 1999; accepted in final form 17 April 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Aaronson, PI,
and
Benham CD.
Alterations in [Ca2+]i mediated by sodium-calcium exchange in smooth muscle cells isolated from the guinea-pig ureter.
J Physiol (Lond)
416:
1-18,
1989
2.
Altiere, RJ,
Olson JW,
and
Gillespie MK.
Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension.
J Pharmacol Exp Ther
236:
390-395,
1986
3.
Archer, SL,
Huang JMC,
Reeve HL,
Hampl V,
Tolarová S,
Michelakis E,
and
Weir EK.
Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia.
Circ Res
78:
431-442,
1996
4.
Furukawa, K,
Ohshima N,
Tawada-Iwata Y,
and
Shigekawa M.
Cyclic GMP stimulates Na+/Ca2+ exchange in vascular smooth muscle cells in primary culture.
J Biol Chem
266:
12337-12341,
1991
5.
Ghodsi, F,
and
Will JA.
Changes in pulmonary structure and function induced by monocrotaline intoxication.
Am J Physiol Heart Circ Physiol
240:
H149-H155,
1981.
6.
Gillespie, MN,
Goldblum SE,
Cohen DA,
and
McClain CJ.
Interleukin 1 bioactivity in the lungs of rats with monocrotaline-induced pulmonary hypertension.
Proc Soc Exp Biol Med
187:
26-32,
1988[Abstract].
7.
Gillespie, MN,
Rippeto PE,
Haven CA,
Shiao RT,
Orlinska U,
Maley BE,
and
Olson JW.
Polyamines and epidermal growth factor in monocrotaline-induced pulmonary hypertension.
Am Rev Respir Dis
140:
1463-1466,
1989[ISI][Medline].
8.
Grynkiewicz, G,
Poenie M,
and
Tsien RY.
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
J Biol Chem
260:
3440-3450,
1985
9.
Hilliker, KS,
Bell TG,
and
Roth RA.
Pneumotoxicity and thrombocytopenia after single injection of monocrotaline.
Am J Physiol Heart Circ Physiol
242:
H573-H579,
1982
10.
Hilliker, KS,
and
Roth RA.
Increased vascular responsiveness in lungs of rats with pulmonary hypertension induced by monocrotaline pyrrole.
Am Rev Respir Dis
131:
46-50,
1985[ISI][Medline].
11.
Ito, K,
Murakami K,
Murakami T,
and
Nakashima T.
Altered function of pulmonary endothelium following monocrotaline-induced lung vascular injury in rats.
Br J Pharmacol
94:
1175-1183,
1988[ISI][Medline].
12.
Lafranconi, WM,
and
Huxtable RJ.
Hepatic metabolism and pulmonary toxicity of monocrotaline using isolated perfused liver and lung.
Biochem Pharmacol
33:
2479-2484,
1984[ISI][Medline].
13.
Lückhoff, A,
and
Busse R.
Calcium influx into endothelial cells and formation of endothelium-derived relaxing factor is controlled by the membrane potential.
Pflügers Arch
416:
305-311,
1990[ISI][Medline].
14.
Ma, X,
Tsao PS,
Viehman GE,
and
Lefer AM.
Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfused cat coronary artery.
Circ Res
69:
95-106,
1991
15.
Madden, JA,
Keller PA,
Effros RM,
Seavitte C,
Choy JS,
and
Hacker AD.
Responses to pressure and vasoactive agents by isolated pulmonary arteries from monocrotaline-treated rats.
J Appl Physiol
76:
1589-1593,
1994
16.
McCarron, JG,
Walsh JV, Jr,
and
Fay FS.
Sodium/calcium exchange regulates cytoplasmic calcium in smooth muscle.
Pflügers Arch
426:
199-205,
1994[ISI][Medline].
17.
Meyrick, B,
Gamble W,
and
Reid L.
Development of Crotalaria pulmonary hypertension: hemodynamic and structural study.
Am J Physiol Heart Circ Physiol
239:
H692-H702,
1980.
18.
Mullins, LJ.
The generation of electric currents in cardiac fibers by Na/Ca exchange.
Am J Physiol Cell Physiol
236:
C103-C110,
1979
19.
Murphy, ME,
and
Brayden JE.
Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels.
J Physiol (Lond)
486:
47-58,
1995[ISI][Medline].
20.
Murphy, ME,
and
Brayden JE.
Apamin-sensitive K+ channels mediate an endothelium-dependent hyperpolarization in rabbit mesenteric arteries.
J Physiol (Lond)
489:
726-734,
1995.
21.
Nagao, T,
and
Vanhoutte PM.
Hyperpolarization contributes to endothelium-dependent relaxations to acetylcholine in femoral veins of rats.
Am J Physiol Heart Circ Physiol
261:
H1034-H1037,
1991
22.
Nakazawa, H,
Hori M,
Ozaki H,
and
Karaki H.
Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats.
Br J Pharmacol
128:
1098-1104,
1999[ISI][Medline].
23.
Ohlstein, EH,
and
Nichols AJ.
Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscle.
Circ Res
65:
917-924,
1989
24.
Peng, W,
Hoidal JR,
Karwande SV,
and
Farrukh IS.
Effect of chronic hypoxia on K+ channels: regulation in human pulmonary vascular smooth muscle cells.
Am J Physiol Cell Physiol
272:
C1271-C1278,
1997
25.
Reindel, JF,
and
Roth RA.
The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells.
Am J Pathol
138:
707-719,
1991[Abstract].
26.
Resta, TC,
Gonzales RJ,
Dail WG,
Sanders TC,
and
Walker BR.
Selective upregulation of arterial endothelial nitric oxide synthase in pulmonary hypertension.
Am J Physiol Heart Circ Physiol
272:
H806-H813,
1997
27.
Suzuki, H,
and
Twarog BM.
Membrane properties of smooth muscle cells in pulmonary hypertensive rats.
Am J Physiol Heart Circ Physiol
242:
H907-H915,
1982
28.
Tabrizchi, R,
MacNicol BJ,
and
Lin BP.
Effects of calcium channel antagonists and pertussis toxin on noradrenaline-induced contractions in pulmonary artery from pulmonary hypertensive rats.
Life Sci
56:
1173-1185,
1995[ISI][Medline].
29.
Tare, M,
Parkington HC,
Coleman HA,
Neild TO,
and
Dusting GJ.
Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium.
Nature
346:
69-71,
1990[Medline].
30.
Van Suylen, RJ,
Smits JF,
and
Daemen MJ.
Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension.
Am J Respir Crit Care Med
157:
1423-1428,
1997
31.
Vorndran, C,
Minta A,
and
Poeni M.
New fluorescence calcium indicators designed for cytosolic retention or measuring calcium near membranes.
Biophys J
69:
2112-2124,
1995
32.
Wanstall, JC,
and
O'Donnell SR.
Endothelin and 5-hydroxytryptamine on rat pulmonary artery in pulmonary hypertension.
Eur J Pharmacol
176:
159-168,
1990[ISI][Medline].
33.
Wanstall, JC,
O'Donnell SR,
and
Kay CS.
Increased relaxation by felodipine on pulmonary artery from rats with monocrotaline-induced pulmonary hypertension does not reflect functional impairment of the endothelium.
Pulm Pharmacol
4:
60-66,
1991[ISI][Medline].
34.
Yamaguchi, K,
Kanai Y,
Asano K,
Takasugi T,
Tanaka T,
Yasuoka M,
and
Hosoda Y.
Temporal alterations of endothelial-vasodilator functions in lung injury induced by monocrotaline.
Respir Physiol
107:
47-58,
1997[ISI][Medline].
35.
Yamamoto, Y,
Imaeda K,
and
Suzuki H.
Endothelium-dependent hyperpolarization and intercellular electrical coupling in guinea-pig mesenteric arterioles.
J Physiol (Lond)
514:
505-513,
1999
36.
Yan, CC,
and
Huxtable RJ.
Quantitation of the hepatic release of metabolites of the pyrrolizidine alkaloid, monocrotaline.
Toxicol Appl Pharmacol
127:
58-63,
1994[ISI][Medline].
37.
Yuan, X-J,
Tod ML,
Rubin LJ,
and
Blaustein MP.
NO hyperpolarizes pulmonary artery smooth muscle cells and decreases the intracellular Ca2+ concentration by activating voltage-gated K+ channels.
Proc Natl Acad Sci USA
93:
10489-10494,
1996
This article has been cited by other articles:
![]() |
X. Sun and D. D. Ku Rosuvastatin provides pleiotropic protection against pulmonary hypertension, right ventricular hypertrophy, and coronary endothelial dysfunction in rats Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H801 - H809. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. M. Hessel, P. Steendijk, B. den Adel, C. I. Schutte, and A. van der Laarse Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2424 - H2430. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Sun and D. D. Ku Allicin in garlic protects against coronary endothelial dysfunction and right heart hypertrophy in pulmonary hypertensive rats Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2431 - H2438. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Sun and D. D. Ku Selective right, but not left, coronary endothelial dysfunction precedes development of pulmonary hypertension and right heart hypertrophy in rats Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H758 - H764. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kanno, Y.-J. L. Wu, P. C. Lee, T. R. Billiar, and C. Ho Angiotensin-Converting Enzyme Inhibitor Preserves p21 and Endothelial Nitric Oxide Synthase Expression in Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats Circulation, August 21, 2001; 104(8): 945 - 950. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |